Market America | SHOP.COM’s Four Steps For A Safe and Pet-Friendly Summer

GREENSBORO, N.C. (PRWEB)
June 25, 2020

Summer is here! While this typically means the kids are finally out of school and are ready to head to camp or play outside with the neighbors, unfortunately this summer is a little different. With most kids having already been home for the past couple of months and typical summer entertainment being temporarily unavailable, parents are looking for the next new and exciting thing their family can look forward to. Look no further!

Summertime, in our opinion, is one of the best times of the year to adopt a pet. With kids at home, playing with pets gives them plenty to do, and when the weather is nice and sunny, there’s more time for the outdoors. If that isn’t convincing enough, a lot of shelters actually reach their peak of animal intake during the summer for reasons such as it’s kitten breeding season. Luckily, and due to current events, pet adoption and fostering has also increased this year, making this surge season a little easier on the local shelters.

One health benefit to adopting a dog that you may not realize comes from studies that show how dog ownership has been associated with reduced risk to cardiovascular disease! Of course, pet ownership comes with a lot of responsibilities, and if you’re not sure it’s the right time for you to adopt, check out the pros and cons first. Most importantly, remember to consider if you can commit both the time and finances it takes to be a responsible pet owner.

Now, if you’ve decided that the pet parent life is for you, or if you already have furry ones running around the house, check out these four steps to make sure your pet has a safe and happy summer.

1. Keep them active

Whether you’re a cat lover, dog lover, or both, it’s important to keep your pets active. Would you like to be cooped up in a crate all day? From laser pointers to going on a walk, there are plenty of options to keep all types of furry friends going. A big hurdle for keeping your pets active, especially dogs, is that the weather can often interfere. From sizzling hot summer pavement to freezing cold icy sidewalks, your dog’s feet can suffer throughout the year. Luckily for us, we can wear shoes to protect our feet from these harsh conditions, but our pets don’t get that luxury! If you ever notice your pet constantly licking, biting or chewing at their paws, it may be a sign that their paws hurt. Constantly licking and chewing their paws can also lead to an infection. One solution is PetHealth™ Pad & Paw Balm. Free of sulfates, phosphate, alcohol, preservatives and paraben, this paw balm cleans and moisturizes, promotes natural healing, heals minor skin irritations and helps maintain skin elasticity. This will help protect their paws from those weather conditions, as well as give them a little TLC after a long day of playing.

2. Keep them clean

Now, cats are usually very self-sufficient and bathe themselves — though if you do run into instances in which they need a bath you can always leave it to the professionals and groomers because we all know how much most cats dislike water! But if you’re a dog owner, you may want to invest in some shampoo. Bathing your dog is a good way to not only help maintain their healthy coats but also double check for any bumps or scratches you might have missed. It’s good to be informed on how to bathe your dog so you can make it as comfortable and safe as possible. For example, while bathing them outside may seem like the easiest option, it’s best to only bathe them outside in warm weather so that they don’t get too cold. It’s also important to learn about your dog’s coat type as this will determine how often they need to be groomed and bathed. While you’re deciding what shampoo is best for your “fur kid,” consider a product that is hypoallergenic and free of phosphates, alcohol, preservatives and paraben like PetHealth Hypoallergenic Shampoo so you can make sure your pup is getting a moisturizing and conditioning bath that won’t irritate their skin.

3. Keep them nourished

There are many factors that can contribute to our pets’ health. From age to breed, some of our pets have a higher chance of developing certain diseases that affect health parameters such as cholesterol and glucose levels. Factors such as activity level, age, diet and more can determine how likely it is for our pets to run into glucose-related issues down the road. On top of you or your vet’s preferred food brand for your cat or dog, you can add a supplement like PetHealth OPC Formula with Glucosamine for Dogs & Cats to make sure your furry friends are getting all of the nutrients they need. The ingredients in PetHealth OPC Formula provide a range of benefits, from helping promote healthy cholesterol levels and cardiovascular health to supporting healthy blood glucose levels. It even combats free radicals that can have a negative effect on your pet’s joints and other tissues. If you’re not sure on what supplements are beneficial for your pup, make sure to read about when supplements should be used before checking out ones such as the PetHealth Multivitamin Formula for Dogs. While this multivitamin helps support your dog’s immune system, promotes digestive health and promotes normal energy levels among many other benefits, it’s always important to check with your vet before adding anything to your pet’s diet!

4. Keep them healthy

While having a furry friend can bring an endless supply of love and joy, it’s also a huge responsibility. Don’t worry, though, because we’re here to help! It’s important to remember that most pets, including dogs and cats, need regular check-ups just like their owners. The good news is things have changed over the years and now there are pet health programs that allow you to get advice from a vet 24/7 without ever leaving your home, and there are some that even provide you with discounts on pet medicines, which can be quite costly. One such program that offers these benefits and more is the Pet Advantage program, created in partnership with Rapid Reward Fulfillment, a company that provides multi-layered health discount solutions throughout the U.S. with individualized enrollment capabilities. This plan includes access to 24/7 TelePet Health through which pet parents can receive advice on behavior, what to do in case of an emergency, wellness care, training, and symptom-related questions, as well as access to a discount veterinarian network, lost-pet recovery service and a discount drug card.

With these tips, we wish you a fun and relaxing summer with your pets!

Market America | SHOP.COM is a global product brokerage and internet marketing company that specializes in one-to-one marketing and is the creator of The Shopping Annuity.

Share article on social media or email:

We’re a homegrown privately owned Florida company that’s proud of our roots. We’re thrilled to be creating jobs and economic growth for communities across our state

SARASOTA, Fla. (PRWEB)
June 25, 2020

AltMed Florida, one of the fastest growing MMTCs in the state (source: OMMU), continues its statewide expansion with a three-day opening, starting Monday June 29 at 10am for its newest MÜV™ Medical Cannabis Dispensary at 8465 Heritage Green Way, Bradenton, FL.

Opening in a busy retail plaza that houses a Crunch Fitness, MÜV’s first dispensary in Bradenton is easily accessible and highly visible off State Road 64 just east of Interstate-75.

AltMed Florida has continued to bring jobs and revitalization to Florida communities during the pandemic – more than doubling its dispensaries from 11 to 23 in 2020 alone.

“The more Floridians become aware of the benefits of medical cannabis the more inquiries we receive from people across the state asking when we’ll open a location in their area,” said Todd Beckwith, AltMed Director of Corporate Affairs. “We’re happy to answer the call and offer our wide range of premium products to residents of Bradenton and Lakewood Ranch. We’re also excited to bring new jobs to the Bradenton economy and help to drive business in the area.”

This MÜV™ Medical Cannabis Dispensary is the third to serve the greater Sarasota market joining dispensaries in on Fruitville Road in Sarasota and on the Tamiami Trail in North Port.

“Being able to bring our world class products to Bradenton is a win win for local patients. They will love what we offer and appreciate our incredibly helpful staff, and the modern, clean, streamlined aesthetic of our dispensaries,” said John Tipton, AltMed Florida CEO. “We’re a homegrown privately owned Florida company that’s proud of our roots. We’re thrilled to be creating jobs and economic growth for communities across our state.”

Deemed an essential service during the pandemic, AltMed Florida has been able to expand its workforce to over 500 employees with additional teams coming onboard at each of its 12 new dispensaries this year. With higher demand for products from 23 total dispensaries, AltMed has also generated additional construction employment and staffing with the expansion of its 220,000-square-foot cultivation facility in Apollo Beach.

During the Bradenton/Lakewood Ranch opening, staggered over three-days (June29-July1) for crowd mitigation, all licensed Florida medical cannabis patients will receive a one-time use only, one per patient, 25 percent off their entire first purchase. Patients are also encouraged to order at muvfl.com for express pickup or delivery to help reduce heavy traffic.

The newest state-of-the-art MÜV™ Lakewood Ranch dispensary will provide award-winning products to medical cannabis patients including an extensive selection of flower, pre-rolls, vaporizer pens, metered dose inhalers, topicals, oral sprays, patent-pending encapsulation formulations in its Tinctures, 72-Hour Transdermal patches and transdermal gels. MÜV also has one of the widest selections of concentrates for patients’ needing macro-dosing options.

Like AltMed Florida’s 22 other locations (Apollo Beach, Bonita Springs, Clearwater, Deerfield Beach, Fort Myers, Gainesville, Jacksonville/San Marco, Jacksonville Beach, Lady Lake, Lakeland, Longwood/Orlando, Lutz, North Port, Downtown Orlando, Ormond Beach, Pensacola, St.Petersburg, Sarasota, Sebastian, Tallahassee, Tampa and Wellington/West Palm), the new Lakewood Ranch MÜV dispensary stands out because it’s designed as a premium experience – think Apple Store, with a modern open-concept design and expert staff with extensive training.

The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards. MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders – only products that license holders make themselves can be sold in their dispensaries.

For more information about the new ADA-compliant MÜV Medical Cannabis Dispensary in Bradenton/Lakewood Ranch, including hours and available MÜV products, visit muvfl.com.

AltMed Florida is on pace to open 40 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 200,000-square-foot, state-of-the-art cultivation facility. Visit this link for images of AltMed Florida’s cultivation operations and watch this brief video to see what makes AltMed Florida and its MÜV™ Medical Cannabis Dispensaries stand out.

About Plants of Ruskin, LLC – d.b.a. AltMed Florida, LLC – With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.

About AltMed Enterprises – Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

About MÜV™ – The MÜV brand of cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary Ethanol extractions that are the basis of all MÜV products.

Forward-Looking Statements – To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

Dr. Allison Britt Kimmins

“In spite of all we know,” notes Dr. Britt Kimmins, “rates of skin cancer continue to rise.”

CHADDS FORD, Pa. (PRWEB)
June 25, 2020

As never before, the chance to get outside under sunny skies is a relief. “It’s been especially welcoming as a result of the COVID-19 Pandemic,” observes Dr. Allison Britt Kimmins, a dermatologist with Advanced Dermatology PC. After weeks spent inside to limit the spread of coronavirus, it is no surprise that we are all anxious to get outside and enjoy the sun. “However” emphasizes Dr. Britt Kimmins, “we want to make sure that we also protect ourselves from the damaging and potentially deadly ultraviolet light.”

Skin cancer is the most common cancer in the world. In the United States, cases outnumber all other cancers combined, according to the non-profit Skin Cancer Foundation.

“In spite of all we know,” notes Dr. Britt Kimmins, “rates of skin cancer continue to rise. In this country, 20% of the population will get skin cancer by the time we’re seventy. Last year, it was estimated that 192,310 people in the U.S. would be diagnosed with melanoma – the deadliest cancer of all.”

The threat of the sun’s ultraviolet rays is so great that the World Health Organization lists them as Group 1 carcinogens, alongside plutonium and cigarettes. The U.S. Department of Health and Human Services also has labeled the sun’s radiation as a known carcinogen. “Ninety percent or more of cases of skin cancer are linked to sun exposure,” states Dr. Britt Kimmins. According to the Skin Cancer Foundation, “having 5 or more sunburns doubles your risk of developing melanoma.” In 2020, it is estimated that the number of melanoma cases is expected to rise.

“Every one of us – regardless of skin tone or age – will benefit from practicing ‘safe sun precautions,’” advises Dr. Britt Kimmins, who makes the following suggestions to enjoy the outdoors safely.

5 Tips to Stay Sun-Safe This Summer – and Year-Round

1. Stick to your skin-checkup schedule: “Early intervention is essential to stay safe from skin cancer. “When detected and treated early, the 5 year survival rate for melanoma is over 98%. Dr. Britt Kimmins recommends that patients see a dermatologist to establish their baseline level of skin health and identify their level of risk. Scheduling regular annual skin examinations will help to monitor the skin for changes and encourage self-examination. This supports early intervention and effective treatment.”

2. Make sure that your sunscreen protects you: “People may think they’re protected when they are not,” warns Dr. Britt Kimmins. “We need to apply enough sunscreen at least 15 minutes before going outdoors and reapply every 2 hours while outside. If swimming or sweating, more frequent reapplication may be necessary. It is important to apply enough sunscreen to all exposed areas including hands, feet, neck, scalp and ears. A one ounce shot glass is the amount needed to cover exposed areas of skin.

3. Remember: You need more than sunscreen: “Even if we follow the American Academy of Dermatology’s guidelines,” notes Dr. Britt Kimmins, “and use a water-resistant product that is SPF 30 or higher with full-spectrum UVA/UVB protection, we cannot completely avoid the sun’s rays. Between 10 a.m. and 2 p.m., when the sun is most direct, we need to be careful: Seek shade and wear protective clothing, including a hat and sunglasses.”

4. Indoor ‘sun’ is just as risky: “Just one indoor tanning session,” Dr. Britt Kimmins emphasizes, “can increase the risk of cancer by almost 70%. Additionally, tanning beds primarily emit UVA rays which penetrate our skin more deeply, further accelerating changes associated with aging.”

5. Pass safe sun habits on to the next generation: “Protecting children and helping young people develop healthy sun habits are keys to reducing skin cancer rates, “states Dr. Britt Kimmins. Just one blistering sunburn during childhood almost doubles the risk of melanoma. Most of the damage occurs before the age of eighteen. Young people are influenced by the behaviors of their caregivers. We see this, for example, with tanning bed use, which often begins during teen years, in the company of a family member.”

“As we all spend time outdoors this summer, “let’s remember our sun-safety suggestions so we can stay healthy now – and skin-cancer-free for years to come.”    

Bio: Allison Britt Kimmins, MD, MPH, is board-certified in dermatology.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York, New Jersey & PA) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

Share article on social media or email:

ERT is innovating clinical trial virtualization through its partnership with Inofab Health, makers of Spirohome, the world’s first ultrasonic personal spirometer.

“This partnership enables ERT to further drive innovation in trial virtualization and supports our commitment to offering the best range of trial continuity options, specifically for sponsors developing new respiratory disease treatments.” – Achim Schülke, EVP Respiratory, ERT.

PHILADELPHIA (PRWEB)
June 25, 2020

ERT, the global leader in clinical endpoints data collection, today announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use. Through the partnership, ERT expands its portfolio of innovative virtual trial solutions to give clinical trial sponsors and contract research organizations (CROs) multiple options for continuing their life-saving research throughout the pandemic and beyond.

Sponsors are looking for reliable data collection methods that enable the continuation of important clinical trials and ensure the safety of clinical trial patients, without requiring them to attend investigative site appointments. ERT is meeting this need with a suite of innovative virtual trial solutions that capture high-quality data from the comfort of patients’ homes.

“We chose to partner with Inofab based on their proven capabilities in meeting respiratory patients’ healthcare needs and their award-winning ultrasonic spirometer, Spirohome,” said Achim Schülke, Executive Vice President of Respiratory Solutions at ERT. “This partnership enables ERT to further drive innovation in trial virtualization and supports our commitment to offering the best range of trial continuity options, specifically for sponsors developing new respiratory disease treatments.”

Since patients with lung disease are at higher risk for developing more serious complications from the COVID-19 illness, many are likely to avoid clinics or investigative sites to minimize their exposure risk. Together, ERT and Inofab will continue to develop patient-friendly, easy to use solutions enabling at-home, patient-administered testing of the lung, supporting patient comfort and safety while ensuring high-quality data collection to keep respiratory trials on track.

“We’re pleased to partner with ERT and to leverage their extensive experience in delivering the important safety and efficacy data sponsors need when developing new respiratory treatments,” said Kerem Yasar, Chief Technology Officer and Co-Founder of Inofab Health. “Spirohome plays a critical role for endpoint data collection and we’re excited to work with ERT in delivering virtual trial solutions that help clinical trial sponsors continue developing new treatments for the millions of patients living with respiratory disease.”

For more information on ERT’s suite of virtual trial solutions, visit virtualtrials.ert.com.

About ERT

ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards.

Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement and measure the efficacy of new clinical treatments while ensuring patient safety. In 2019, 75% of all FDA drug approvals came from ERT-supported studies. Pharma companies, biotechs, and CROs have relied on ERT solutions across 15,000 studies, spanning more than four million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly ─ and with confidence.

For more information, go to ert.com or follow us on LinkedIn and Twitter.

About Inofab Health

Inofab Health offers revolutionizing respiratory care solutions for home and professional use with a human-centric approach and cutting-edge technology. It provides a functional respiratory care management platform along with ultrasonic personal & clinic spirometers and connected inhaler attachments. Inofab Health alerts any declines in lung health, allowing quick intervention against symptom onset and prevents unnecessary hospitalisations.

For further information see https://Inofab.health.

Share article on social media or email:

We look forward to utilizing Genedata Profiler and Genedata Managed IT Services to assist us in our mission to develop safe, targeted, effective therapeutics for cancer patients

BASEL, Switzerland (PRWEB)
June 25, 2020

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that it has entered into a multi-year contract with Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to discover and develop ground-breaking drugs. The agreement includes a software license to the Genedata Profiler® platform as well as a variety of service arrangements, including consulting services and Managed IT Services, a recently added offering to the Genedata Service Portfolio.

Under the terms of the agreement, Genedata is committed to maintaining full operational responsibility for the software. In addition, Genedata has agreed to provide consulting services for workflow setup, data integration, and user training to get Merus productive with Genedata Profiler quickly and efficiently.

“Our unique technology uses large-scale functional screening in molecular and cell-based assays to identify unique oncology therapeutic multispecific antibody candidates from among thousands tested against an array of targets,” said John de Kruif, Ph.D., Chief Technology Officer of Merus. “We have long understood and valued the importance of being able to collect and analyze complex data sets in order to optimize the discovery of new combinations and modes of action. As we expect our clinical and pre-clinical programs and pipeline to continue to grow, we look forward to utilizing Genedata Profiler and Genedata Managed IT Services to assist us in our mission to develop safe, targeted, effective therapeutics for cancer patients.”

Genedata Profiler permits Merus’ scientists to leverage all the data and knowledge from past, current and future preclinical experiments and clinical trials, facilitating efficient translational and reverse translational research. It fosters secure collaboration between internal and external research groups and empowers users to make data-informed decisions with powerful, well-engineered analytical tools. Genedata Profiler depicts and tracks the whole data life cycle in a secure way with easy-to-use, fully configurable workflows, straight out of the box.

“We are excited to add Merus, a leading innovator in the oncology and multispecific antibody space, to our rapidly growing list of biopharmaceutical companies that have recognized the value that Genedata Profiler can bring to their translational and clinical research programs”, said Othmar Pfannes, Ph.D., CEO of Genedata. “With the expansion of our services portfolio to include Managed IT Services, we also demonstrate our commitment to medium sized biopharmaceutical companies who are looking for an all-in-one service provider. We remain committed to supporting our customers in making their R&D processes more efficient and scalable.”

About Genedata

Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.

http://www.genedata.com

LinkedIn | Twitter | YouTube

Contact

Miles Fisher-Pollard

Genedata

Public Relations

Phone: +41 61 511 85 61

pr@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Share article on social media or email: